Potential Medicare Part D Savings on Ophthalmic Generic Drugs-Reference-Cited by-同舟云学术

Potential Medicare Part D Savings on Ophthalmic Generic Drugs

Published:2024-07-01 Issue:7 Volume:142 Page:678
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Collet David A.¹,Urban Matthew B.¹,Amin Abha²

Affiliation:

1. School of Medicine, New York Medical College, Valhalla

2. Department of Ophthalmology, Westchester Medical Center, Valhalla, New York

Abstract

This economic evaluation assesses potential Medicare Part D savings on ophthalmic generic drugs if discount coupon prices are used.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2819220/jamaophthalmology_collet_2024_ld_240004_1719935981.065.pdf

Reference6 articles.

1. Ophthalmic medication expenditures and out-of-pocket spending: an analysis of United States prescriptions from 2007 through 2016.;Chen;Ophthalmology,2020

2. Drug savings for Medicare Part D beneficiaries using a direct-to-consumer model.;Berkowitz;Ophthalmology,2024

3. Congressional Budget Office. Prescription drugs: spending, use, and prices. 2022. Accessed December 6, 2023. https://www.cbo.gov/publication/57772#_idTextAnchor004

4. Cubanski? J, Neuman? T. A small number of drugs account for a large share of Medicare Part D spending. KFF. July 12, 2023. Accessed December 6, 2023. https://www.kff.org/medicare/issue-brief/a-small-number-of-drugs-account-for-a-large-share-of-medicare-part-d-spending/

5. DrugBank Online. Home page. Accessed April 6, 2023. https://go.drugbank.com/

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Pricing Stewardship from Mark Cuban’s Cost Plus Generic Drug Program;PharmacoEconomics;2024-08-21